Peptides · Peptide comparison
Alexamorelin vs Ipamorelin
A next-generation growth hormone releaser that converts to hexarelin in your body for enhanced GH, cortisol, and unique aldosterone stimulation.
A uniquely selective growth hormone booster that tells your pituitary to release more GH without messing with your cortisol or other hormones—making it the 'clean' choice among growth hormone peptides.
- Growth Hormone
- Growth Hormone
At a glance
Quick comparison
Efficacy
Benefit ratings
Growth Hormone Release
Hormone Axis Stimulation
Research & Innovation
GH Selectivity
Recovery Support
Safety Profile
Technical data
Compound specifications
Alexamorelin
- Molecular formula
- C50H63N13O7
- Molecular weight
- 958.1 g/mol
- Half-life
- Estimated 1-3 hours (rapidly metabolized to hexarelin)
- Bioavailability
- Active IV and orally; subcutaneous bioavailability expected moderate to good
- CAS number
- 196808-85-2
Ipamorelin
- Molecular formula
- C38H49N9O5
- Molecular weight
- 711.85 g/mol
- Half-life
- 2 hours
- Bioavailability
- High when injected subcutaneously
- CAS number
- 170851-70-4
Protocols
Dosing compared
Alexamorelin
Intravenous
- 1.0 mcg/kgSingle bolus per test session · Single-dose research studyAlexamorelin is a research growth-hormone-releasing peptide. In the main human study it was given as a single shot into a vein. The lower 1.0 mcg/kg dose raised growth hormone levels. [1]
- 2.0 mcg/kgSingle bolus per test session · Single-dose research studyThe higher IV dose used in the same human study produced a stronger growth hormone response. [1]
Oral
- 20 mg (about 300 mcg/kg)Single dose · Single-dose research studyAlexamorelin also works by mouth. A 20 mg oral dose (roughly 300 mcg/kg) released growth hormone in the human study, showing it stays active when swallowed. [1][3]
Ipamorelin
Subcutaneous
- 100 mcg per injection2-3 times daily · 4-8 weeksConservative entry dose; Ipamorelin is a selective GH secretagogue with a ~2 hour half-life, so doses are split through the day [1][2]. Used in research and practice to assess tolerance before titrating up.
- 200 mcg per injection2-3 times daily · 8-12 weeksMost commonly cited research/practice dose; gives a meaningful pulsatile GH release without raising cortisol or prolactin at standard doses [1][2].
- 300 mcg per injection3 times daily · 8-12 weeksUpper end of the commonly used range; total daily exposure split across three injections. Used in practice by experienced users [1].
Applications
Best suited for
Alexamorelin
- Muscle Builders and Athletes
- Alexamorelin's potent GH release makes it ideal for those serious about muscle gains. Its stronger ACTH response compared to hexarelin provides additional recovery benefits, though the cortisol elevation requires monitoring. The oral option is convenient for athletes avoiding injections, though subcutaneous injection remains most practical.
- Research-Focused Peptide Users
- If you're exploring next-generation GHS compounds, alexamorelin offers a fascinating case study: it's a prodrug that becomes hexarelin in your body, offering a unique window into peptide metabolism. This makes it valuable for understanding how compound modifications affect potency and half-life.
- Synergistic Stack Enthusiasts
- Alexamorelin shines when stacked with GHRH, creating synergistic GH release that exceeds either alone. It also pairs well with recovery-focused peptides like BPC-157, making it the centerpiece of comprehensive growth protocols.
Ipamorelin
- Clean GH Boost Seekers
- If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release.
- Recovery-Focused Athletes
- Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects.
- Anti-Aging Enthusiasts
- Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy.
- Those Recovering from Steroid Use
- Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost.
Safety profile
Side effects
Alexamorelin
Common
- Increased Hunger
- Water Retention
- Injection Site Reactions
Uncommon
- Cortisol-Related Mood Changes
- Joint or Muscle Aches
Serious
- Allergic Reaction
Ipamorelin
Common
- Mild headache
- Injection site reactions
- Water retention
- Increased appetite
Uncommon
- Tingling in hands or feet
- Joint stiffness
Serious
- Allergic reaction
Research status
Safety & evidence
Alexamorelin
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Alexamorelin is a research compound with only one small human study (6 subjects), making it much less proven than hexarelin. While it shows promise as a potent GH releaser, the limited human evidence means we don't fully understand long-term effects, optimal dosing in different populations, or rare side effects. Its unique stronger ACTH and aldosterone effects require careful monitoring. Always start low and monitor how your body responds.
Contraindications
- Active malignancy or cancer history (GH stimulation concern)
- Uncontrolled diabetes or severe glucose dysregulation
- Severe cardiovascular disease or unmanaged hypertension
- Pregnancy or nursing
Ipamorelin
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Ipamorelin's main selling point is that it raises growth hormone without raising cortisol or ACTH — two stress hormones that similar peptides do raise. That was shown in pigs, and it held even at doses more than 200 times higher than the amount needed to raise growth hormone [1]. It has not been checked in people. The two published human studies measured ipamorelin and growth hormone only; neither one assayed cortisol, ACTH or prolactin [2][3]. Most of what we know about safety in people comes from a single trial in patients recovering from bowel surgery. 114 people took part: 56 got ipamorelin through an IV for up to seven days, and 58 got a placebo. Most side effects were mild to moderate, and were the kind you would expect after surgery [3]. Serious problems happened at about the same rate in both groups — roughly 1 in 6 either way (17.9% on ipamorelin, 15.5% on placebo). But three things were more common on ipamorelin: low potassium in about 1 in 8 people versus about 1 in 30 on placebo (12.5% vs 3.4%), trouble sleeping in about 1 in 9 versus about 1 in 19 (10.7% vs 5.2%), and high blood sugar at discharge in about 1 in 7 versus about 1 in 12 (14.3% vs 8.6%) [6]. Two people taking ipamorelin died. Both had colon cancer surgery, and in both cases the surgical join in the bowel leaked afterward. Nobody on the placebo died. The FDA says it is unclear whether those deaths had anything to do with ipamorelin — but it pointed to them, along with the potassium and blood sugar differences, when it recommended in October 2024 against letting pharmacies compound ipamorelin [6].
Contraindications
- Active cancer or history of cancer
- Pregnancy or breastfeeding
- Pituitary disorders or tumors
- Known allergy to peptide components
- Children and adolescents (growth plates still open)
Decision guide
Which is right for you?
Alexamorelin
Choose Alexamorelin if…
- Maximizing growth hormone release for muscle building
- Cycling with other peptides for synergistic GH stack effects
- Research into next-generation GHS compounds
- Understanding prodrug metabolism in peptide design
Ipamorelin
Choose Ipamorelin if…
- Muscle recovery and growth
- Anti-aging and vitality
- Body composition improvement
- Sleep quality enhancement